These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28720173)

  • 1. Simultaneous Determination of First-Line 4-FDC Antituberculosis Drugs by UHPLC-UV and HPLC-UV: A Comparative Study.
    Franco PHC; Chellini PR; Oliveira MAL; Pianetti GA
    J AOAC Int; 2017 Jul; 100(4):1008-1015. PubMed ID: 28720173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Determination of First-Line 4-FDC Antituberculosis Drugs by UHPLC-UV and HPLC-UV: A Comparative Study.
    Franco PH; Chellini PR; Oliveira MA; Pianetti GA
    J AOAC Int; 2017 Jan; ():. PubMed ID: 28105975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of an HPLC Method for Simultaneous Determination of Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride in Pharmaceutical Formulations.
    Chellini PR; Lages EB; Franco PH; Nogueira FH; César IC; Pianetti GA
    J AOAC Int; 2015; 98(5):1234-9. PubMed ID: 26525241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets.
    Shewiyo DH; Kaale E; Risha PG; Dejaegher B; Smeyers-Verbeke J; Vander Heyden Y
    J Chromatogr A; 2012 Oct; 1260():232-8. PubMed ID: 22981506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.
    Mohan B; Sharda N; Singh S
    J Pharm Biomed Anal; 2003 Mar; 31(3):607-12. PubMed ID: 12615251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
    Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
    APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation.
    Calleri E; De Lorenzi E; Furlanetto S; Massolini G; Caccialanza G
    J Pharm Biomed Anal; 2002 Aug; 29(6):1089-96. PubMed ID: 12110394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules.
    Ellard GA
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S343-6; discussion S351-2. PubMed ID: 10593715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatographic determination of isoniazid, pyrazinamide and rifampicin from pharmaceutical preparations and blood.
    Khuhawar MY; Rind FM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):357-63. PubMed ID: 11829003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of rifampicin, isoniazid and pyrazinamide in tablet preparations by multivariate spectrophotometric calibration.
    Goicoechea HC; Olivieri AC
    J Pharm Biomed Anal; 1999 Aug; 20(4):681-6. PubMed ID: 10704137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of rifampicin, isoniazid and pyrazinamid by high performance thin layer chromatography.
    Argekar AP; Kunjir SS; Purandare KS
    J Pharm Biomed Anal; 1996 Aug; 14(11):1645-50. PubMed ID: 8877875
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
    Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y
    Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatographic analysis of antituberculosis drugs in biological samples.
    Holdiness MR
    J Chromatogr; 1985 May; 340():321-59. PubMed ID: 2410437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of contents and dissolution of ethambutol hydrochloride in fixed dose combinations for antituberculosis drugs by high performance liquid chromatography with pre-column derivatization].
    Sun J; Song H; Zhang T; Wang Z; He Z
    Se Pu; 2006 Mar; 24(2):164-7. PubMed ID: 16830466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of near infrared spectroscopy in rapid and simultaneous determination of essential components in five varieties of anti-tuberculosis tablets].
    Teng LS; Wang D; Song J; Zhang YB; Guo WL; Teng LR
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1814-8. PubMed ID: 18975810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of a stability-indicating HPLC method for the simultaneous determination of rifampicin, isoniazid, and pyrazinamide in a fixed-dose combination using artificial neural networks.
    Glass BD; Agatonovic-Kustrin S; Chen YJ; Wisch MH
    J Chromatogr Sci; 2007 Jan; 45(1):38-44. PubMed ID: 17254382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
    Bhutani H; Singh S; Jindal KC; Chakraborti AK
    J Pharm Biomed Anal; 2005 Oct; 39(5):892-9. PubMed ID: 15978767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):474-81. PubMed ID: 12395981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
    Song SH; Jun SH; Park KU; Yoon Y; Lee JH; Kim JQ; Song J
    Rapid Commun Mass Spectrom; 2007; 21(7):1331-8. PubMed ID: 17340570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.
    Panchagnula R; Sood A; Sharda N; Kaur K; Kaul CL
    J Pharm Biomed Anal; 1999 Jan; 18(6):1013-20. PubMed ID: 9925337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.